/People

Catherine Stehman-Breen

Investor

Venture Partner at F-Prime Capital

Cambridge

Find your path to Catherine

Sign up to see every warm intro you have to Catherine

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Catherine. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Venture Partner at F-Prime based in the Cambridge office, focused on new company creation, with over 30 years of medical and biopharmaceutical experience. She previously served as CEO of Chroma Medicine, CRDO at Obsidian Therapeutics, EIR at Atlas Venture, and CMO at Sarepta Therapeutics, and holds an MD from the University of Chicago and an MS in epidemiology from the University of Washington.

Invests in

Biotech

Deals · 1

Generation BioBoard seat

via F-Prime Capital · filed Mar 2018 · $100.4M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at F-Prime Capital

Frequently asked questions

Who is Catherine Stehman-Breen?
Venture Partner at F-Prime based in the Cambridge office, focused on new company creation, with over 30 years of medical and biopharmaceutical experience. She previously served as CEO of Chroma Medicine, CRDO at Obsidian Therapeutics, EIR at Atlas Venture, and CMO at Sarepta Therapeutics, and holds an MD from the University of Chicago and an MS in epidemiology from the University of Washington.
Where does Catherine Stehman-Breen work?
Catherine Stehman-Breen is Venture Partner at F-Prime Capital.
What does Catherine Stehman-Breen invest in?
Catherine Stehman-Breen invests in Biotech.
What boards does Catherine Stehman-Breen sit on?
Catherine Stehman-Breen holds tracked board seats at Generation Bio.

About this profile. Compiled from public sources — F-Prime Capital's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights